News
Parmax Pharma reports standalone net profit of Rs 0.17 crore in the September 2026 quarter
17-Nov-2026 | 07:40
Sales rise 362.45% to Rs 11.70 crore
Net profit of Parmax Pharma reported to Rs 0.17 crore in the quarter ended September 2026 as against net loss of Rs 2.08 crore during the previous quarter ended September 2025. Sales rose 362.45% to Rs 11.70 crore in the quarter ended September 2026 as against Rs 2.53 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 11.70 | 2.53 | 362 |
| OPM % | -11.62 | -62.85 | - |
| PBDT | 0.66 | -1.82 | LP |
| PBT | 0.17 | -2.08 | LP |
| NP | 0.17 | -2.08 | LP |
Powered by Capital Market - Live News